A Multicenter Phase II Study with Triptorelin (Sustained-Release LHRH Agonist) in Advanced or Recurrent Endometrial Carcinoma: A French Anticancer Federation Study
| Autor: | Lhommé, C., Vennin, P., Callet, N., Lesimple, T., Achard, J.L., Chauvergne, J., Luporsi, E., Chinet-Charrot, P., Coudert, B., Couette, J.E., Guastalla, J.P., Lebrun, D., Ispas, S., Blumberg, J. |
|---|---|
| Zdroj: | In Gynecologic Oncology November 1999 75(2):187-193 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect